MTOR and cancer: Alterations in the mTOR signaling pathway have been associated with various human pathologies, notably liver diseases, and have also been correlated with the inhibition of cancer cell growth through suppression of the AKT/PI3K/mTOR axis [110,144] (Figure 5).